East Carolina University
 
Leo W. Jenkins Cancer Center
Adam Asch, MD


ECU sign
Printer Friendly


 


Adam Asch, MD
 

Professor
Division Chief
Associate Director of Leo Jenkins Cancer Center

Undergraduate: Swarthmore College
Medical School: Thomas Jefferson Medical College
Residency: Long Island Jewish Hillside Medical Center
Fellowship: The New York Hospital / Weill-Cornell University Medical College Certifications

Board Certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine  

Clinical Services

Hematology 
    • Leukemia  
     • Lymphoma
     • CNS Lymphoma 
     • Myelodysplastic Syndrome 
    
• Myeloproliferative Diseases
      Thrombotic & Bleeding Disorders
     • Stem Cell Disorders

Subspeciality :   Hematology/Oncology

Research Interests: 

               • Thrombotic & Bleeding Disorders
            • Hematological Malignancies
            
• Stem Cell Disorders

Selected Publications

Wiestner A, Cho HJ, Asch AS, Michelis MA, Zeller JA, Peerschke EI, Weksler BB, Schechter GP. Rituximab in the treatment of acquired factor VIII inhibitors. Blood. 2002 Nov 1;100(9):3426-8.

Griffin E, Re A, Hamel N, Fu C, Bush H, McCaffrey T, Asch AS. A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. Nat Med. 2001 Jul;7(7):840-6.

Simantov R, Febbraio M, Crombie R, Asch AS, Nachman RL, Silverstein RL. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest. 2001 Jan;107(1):45-52.